Mark Kindy to Drug Evaluation, Preclinical
This is a "connection" page, showing publications Mark Kindy has written about Drug Evaluation, Preclinical.
Connection Strength
0.017
-
Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. J Biol Chem. 2008 Mar 21; 283(12):7745-53.
Score: 0.017